Morning Overview on MSN
Cell motion might be a hidden power source in biology
Inside every living cell, proteins and membranes are in constant motion, reshaping, colliding, and flexing as they keep an ...
The Brighterside of News on MSN
New study provides a key breakthrough in cancer therapy and synthetic biology
Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.
Morning Overview on MSN
New research links cancer therapy and synthetic biology in a major leap
Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...
ZME Science on MSN
Scientists Say the Constant Motion of Living Cells Could Be a Hidden Source of Electrical Power
The constant, energy-driven motion inside living cells may generate electricity in a way no one fully recognized before.
Researchers from Kyushu University have developed an innovative computational method, called ddHodge, that can reconstruct ...
SAN DIEGO--(BUSINESS WIRE)--In an exciting moment for genomics research, Scale Biosciences (Scale Bio) announced today the winning projects of the 100 Million Cell Challenge representing more than a ...
ZME Science on MSN
Meet Stephen Quake: The Scientist Who Treats Biology like Physics and Turned Life Into Data
Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.
Researchers can now order their mutation of choice in bit.bio’s opti-ox TM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated ...
News Medical on MSN
Cell batteries: condensates charge the membrane
Researchers have determined that condensates are electrically charged droplets that can induce voltage changes across the ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...
The disease-relevant mutation is engineered into bit.bio’s human ioWild Type TM cells using CRISPR/Cas9 gene editing. As disease model cells come from an identical human genetic background to ioWild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results